Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats
- PMID: 22444202
- DOI: 10.1016/j.biopsych.2012.01.035
Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats
Abstract
Background: Roux-en-Y gastric bypass (RYGB) surgery is an effective weight loss strategy employed to treat obesity and associated complications. Importantly, the RYGB procedure has been reported to attenuate reward-related consummatory behaviors. The present work examined the hypothesis that RYGB surgery attenuates ethanol intake and reward in the context of frequent ethanol consumption.
Methods: To do this, self-report of ethanol intake was examined in human bariatric patients (n = 6165) before and following the RYGB procedure. In addition, we utilized a rodent model of RYGB and examined ethanol consumption and ethanol reward in male ethanol-preferring (P) rats, which are selectively bred to consume large volumes of ethanol.
Results: Patients that reported frequent consumption of ethanol before RYGB reported decreased consumption following RYGB surgery. Moreover, the RYGB procedure decreased ethanol intake and the reinforcing properties of ethanol in P rats. Notably, the attenuating effect of RYGB surgery on ethanol consumption was associated with ethanol-induced increases in the gut hormone glucagon-like peptide-1 (GLP-1). Pharmacologic administration of GLP-1 agonists attenuated ethanol consumption in sham P rats. In addition, pharmacologic replacement of the gut hormone ghrelin restored drinking behavior in P rats following RYGB.
Conclusions: Collectively, these findings unveil the potential of RYGB surgery to attenuate ethanol consumption in some humans and rats. Furthermore, our data indicate that this regulation is achieved, in part, through reduction of reward and is modified by the gut hormones GLP-1 and ghrelin.
Copyright © 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Effect of vertical sleeve gastrectomy on alcohol consumption and preferences in dietary obese rats and mice: A plausible role for altered ghrelin signaling.Brain Res Bull. 2018 Apr;138:26-36. doi: 10.1016/j.brainresbull.2017.08.004. Epub 2017 Aug 9. Brain Res Bull. 2018. PMID: 28802901 Free PMC article.
-
Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.Surgery. 2005 Aug;138(2):283-90. doi: 10.1016/j.surg.2005.05.013. Surgery. 2005. PMID: 16153438
-
Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.Circulation. 2015 Mar 10;131(10):871-81. doi: 10.1161/CIRCULATIONAHA.114.011791. Epub 2015 Feb 11. Circulation. 2015. PMID: 25673670
-
Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes.Diabetes Obes Metab. 2012 Apr;14(4):291-8. doi: 10.1111/j.1463-1326.2011.01505.x. Epub 2011 Nov 13. Diabetes Obes Metab. 2012. PMID: 21951387 Review.
-
Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.Int J Clin Pract Suppl. 2010 Feb;(166):53-8. doi: 10.1111/j.1742-1241.2009.02279.x. Int J Clin Pract Suppl. 2010. PMID: 20377665 Review.
Cited by
-
A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder.Brain Sci. 2024 Mar 20;14(3):294. doi: 10.3390/brainsci14030294. Brain Sci. 2024. PMID: 38539681 Free PMC article. Review.
-
Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity.Sci Rep. 2023 Nov 28;13(1):20998. doi: 10.1038/s41598-023-48267-2. Sci Rep. 2023. PMID: 38017205 Free PMC article.
-
Antismoking agents do not contribute synergistically to semaglutide's ability to reduce alcohol intake in rats.Front Pharmacol. 2023 Aug 31;14:1180512. doi: 10.3389/fphar.2023.1180512. eCollection 2023. Front Pharmacol. 2023. PMID: 37719854 Free PMC article.
-
Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice.Neuropharmacology. 2023 Nov 1;238:109643. doi: 10.1016/j.neuropharm.2023.109643. Epub 2023 Jun 25. Neuropharmacology. 2023. PMID: 37369277
-
Actions of feeding-related peptides on the mesolimbic dopamine system in regulation of natural and drug rewards.Addict Neurosci. 2022 Jun;2:100011. doi: 10.1016/j.addicn.2022.100011. Epub 2022 Feb 26. Addict Neurosci. 2022. PMID: 37220637 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials